Improving the Diagnosis and Follow-Up of Chronic Myeloid Leukemia Using Conventional and Molecular Techniques. [PDF]
Bahar NAA, Al-Ouqaili MTS, Talib NM.
europepmc +1 more source
FusionPub, a therapeutic landscape of human fusion genes. [PDF]
Kumar H, Adegunlehin A, Chen Z, Kim P.
europepmc +1 more source
Imatinib-Induced Bone Marrow Aplasia in Chronic Myelogenous Leukemia. [PDF]
Dogra R, Dogra V, Shelke AR.
europepmc +1 more source
Discovery of <i>N</i>-(2-Acetamidobenzo[<i>d</i>]thiazol-6-yl)-2-phenoxyacetamide Derivatives as Novel Potential BCR-ABL1 Inhibitors Through Structure-Based Virtual Screening. [PDF]
Wang S, Wang M, Li Z, Xu G, Wang D.
europepmc +1 more source
T cell receptors specific for an imatinib-induced mutation in BCR-ABL for adoptive T cell therapy. [PDF]
Hsu MT+3 more
europepmc +1 more source
COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity. [PDF]
He N, Li G, Liu J, Liu W, Tian R, Ma D.
europepmc +1 more source
Impact of Tyrosine Kinase Inhibitors on the Expression Pattern of Epigenetic Regulators. [PDF]
Tóth K, Gaál Z.
europepmc +1 more source
Imatinib-Induced Clinical Response in ETV6::ACSL6 Myeloid Neoplasm with Eosinophilic Pneumonitis: A Case Report. [PDF]
Hoff FW+11 more
europepmc +1 more source
Low-dose dasatinib-induced chylothorax, pulmonary hypertension, and pericardial effusion in a patient with chronic myeloid leukemia: A case report and literature review. [PDF]
Pai TW, Huang CW.
europepmc +1 more source
Chronic Myeloid Leukemia with a Rare Philadelphia Chromosome Variant Involving Chromosome 16. [PDF]
Bahashwan SM.
europepmc +1 more source